Meanwhile breast cancer cell lines have shown an increase in Src activity compared with normal breast tissue [8, 9], while conversely treatment with a pharmacological Src inhibitor results in decreased cell motility and a less invasive cellular phenotype [11]. The gene discussed is SRC; the disease is breast cancer.